JMP Securities

Selected news for the capital firm - JMP Securities, collected since 10/2017. This capital firm shares healthcare news with Veeva Systems, Wolfe Research, Model N, Veeva and dozens of others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
1/12/2022 Zacks Investment Research Lowers Apyx Medical (NASDAQ:APYX) to Sell - Ticker Report Ticker Report ... have also weighed in on APYX. Piper Sandler boosted their price target on Apyx Medical from $14.00 to $20.00 and gave the stock an overweight rating in a research note on Thursday, November 11th. JMP Securities restated a buy rating and set a $17.00 price target on shares of Apyx Medical in a research note on Friday, November 12th.APYX opened at $13.00 on Tuesday. The company has a 50 ...
1/12/2022 Zogenix (NASDAQ:ZGNX) Downgraded to Sell at Zacks Investment Research - Slater Sentinel slatersentinel.com ... no treatment options. The company is currently pursuing two therapies targeting the Dravet Syndrome and the Lennox-Gastaut Syndrome. “Get Zogenix alerts: Several other equities analysts have also weighed in on the company. JMP Securities reaffirmed a buy rating and issued a $62.00 price objective on shares of Zogenix in a research note on Friday, November 5th. SVB Leerink reduced their price objective on Zogenix from $37.00 to $32.00 ...
1/12/2022 Zacks Investment Research Lowers Zogenix (NASDAQ:ZGNX) to Sell - Transcript Daily transcriptdaily.com ... or no treatment options. The company is currently pursuing two therapies targeting the Dravet Syndrome and the Lennox-Gastaut Syndrome. “Get Zogenix alerts: Other analysts have also issued research reports about the company. JMP Securities reissued a buy rating and issued a $62.00 target price on shares of Zogenix in a research report on Friday, November 5th. SVB Leerink decreased their target price on shares of Zogenix from $37.00 ...
1/11/2022 Morgan Stanley Lowers Teleflex (NYSE:TFX) to Equal Weight dispatchtribunal.com ... recently issued reports about the company. Raymond James dropped their price target on Teleflex from $440.00 to $391.00 and set an outperform rating on the stock in a research report on Friday, October 29th. JMP Securities reduced their price objective on Teleflex from $470.00 to $430.00 and set a market outperform rating on the stock in a research note on Friday, October 29th. Piper Sandler lowered Teleflex from an overweight ...
1/11/2022 Zacks Investment Research Downgrades Syros Pharmaceuticals (NASDAQ:SYRS) to Sell zolmax.com ... a number of other research reports. Roth Capital lifted their price target on Syros Pharmaceuticals from $20.00 to $23.00 and gave the stock a buy rating in a research report on Thursday, September 23rd. JMP Securities reiterated a buy rating and set a $20.00 price objective on shares of Syros Pharmaceuticals in a research note on Tuesday, September 21st. Finally, HC Wainwright restated a buy rating on shares of Syros ...
1/11/2022 Zacks Investment Research Downgrades Innovative Industrial Properties (NYSE:IIPR) to Sell baseballnewssource.com ... on the acquisition, ownership and management of specialized industrial properties leased to experienced, state-licensed operators for medical-use cannabis facilities. Innovative Industrial Properties, Inc. is based in San Diego, United States. “Separately, JMP Securities increased their target price on Innovative Industrial Properties from $260.00 to $300.00 and gave the stock an “outperform” rating in a research note on Thursday, November 4th. One equities research analyst has rated ...
1/11/2022 Haemonetics (NYSE:HAE) PT Lowered to $60.00 at Morgan Stanley - Slater Sentinel slatersentinel.com ... published on Friday, Price Targets.com reports. Morgan Stanley currently has an equal weight rating on the medical instruments supplier’s stock.A number of other analysts have also recently issued reports on the company. JMP Securities reduced their price objective on Haemonetics from $90.00 to $80.00 and set an outperform rating for the company in a research report on Wednesday, November 10th. Raymond James reduced their price objective on Haemonetics ...
1/11/2022 eFFECTOR Therapeutics (NASDAQ:EFTR) Downgraded by Zacks Investment Research to “Sell” Daily Political ... for the company. Stifel Nicolaus upgraded shares of eFFECTOR Therapeutics from a hold rating to a buy rating and set a $20.00 price target for the company in a report on Monday, November 8th. JMP Securities initiated coverage on shares of eFFECTOR Therapeutics in a report on Tuesday, September 21st. They set an outperform rating and a $33.00 price target for the company. Cantor Fitzgerald initiated coverage on shares of ...
1/11/2022 eFFECTOR Therapeutics (NASDAQ:EFTR) Downgraded to Sell at Zacks Investment Research - Ticker Report Ticker Report ... the company. Stifel Nicolaus raised shares of eFFECTOR Therapeutics from a hold rating to a buy rating and set a $20.00 price objective for the company in a research report on Monday, November 8th. JMP Securities started coverage on shares of eFFECTOR Therapeutics in a research report on Tuesday, September 21st. They issued an outperform rating and a $33.00 price objective for the company. Credit Suisse Group started coverage on ...
1/11/2022 Zimmer Biomet Holdings, Inc. Forecasted to Post FY2021 Earnings of $7.40 Per Share (NYSE:ZBH) Daily Political ... earnings at $8.45 EPS, FY2023 earnings at $9.18 EPS, FY2024 earnings at $9.91 EPS and FY2025 earnings at $10.55 EPS. Get Zimmer Biomet alerts:Other equities analysts also recently issued reports about the stock. JMP Securities lowered their target price on shares of Zimmer Biomet from $195.00 to $175.00 and set a “market outperform” rating on the stock in a report on Friday, November 5th. Truist Securities lowered their ...
1/11/2022 Brokers Issue Forecasts for Integra LifeSciences Holdings Co.'s FY2021 Earnings (NASDAQ:IART) - Ticker Report Ticker Report ... a number of other reports. Credit Suisse Group increased their price target on Integra LifeSciences from $84.00 to $87.00 and gave the stock an “outperform” rating in a report on Wednesday, November 3rd. JMP Securities reiterated a “buy” rating on shares of Integra LifeSciences in a research report on Wednesday, November 3rd. JPMorgan Chase & Co. raised Integra LifeSciences from an “underweight” rating to a “neutral” rating ...
1/11/2022 Zacks Investment Research Downgrades Innovative Industrial Properties (NYSE:IIPR) to Sell com-unik.info ... on the acquisition, ownership and management of specialized industrial properties leased to experienced, state-licensed operators for medical-use cannabis facilities. Innovative Industrial Properties, Inc. is based in San Diego, United States. “Separately, JMP Securities boosted their price objective on Innovative Industrial Properties from $260.00 to $300.00 and gave the stock an “outperform” rating in a research note on Thursday, November 4th. One equities research analyst has rated ...
1/11/2022 Kura Oncology (NASDAQ:KURA) Downgraded by Zacks Investment Research - Transcript Daily transcriptdaily.com ... research note on Friday. HC Wainwright reduced their price objective on Kura Oncology from $43.00 to $32.00 and set a “buy” rating for the company in a research note on Wednesday, November 24th. JMP Securities reiterated a “buy” rating and issued a $26.00 price objective on shares of Kura Oncology in a research note on Wednesday, December 15th. Wedbush reiterated an “outperform” rating on shares of Kura ...
1/11/2022 ProQR Therapeutics (NASDAQ:PRQR) Downgraded to “Hold” at Zacks Investment Research modernreaders.com ... product candidate includes QR-010, a RNA-based oligonucleotide for the treatment of cystic fibrosis. ProQR Therapeutics B.V. is headquartered in Leiden, the Netherlands. “Several other research firms also recently commented on PRQR. JMP Securities reissued a buy rating and set a $31.00 price objective on shares of ProQR Therapeutics in a report on Thursday, September 30th. Cantor Fitzgerald reissued an overweight rating on shares of ProQR Therapeutics in ...
1/10/2022 BMO Capital Markets Boosts Kura Oncology (NASDAQ:KURA) Price Target to $80.00 zolmax.com Kura Oncology (NASDAQ:KURA) had its target price lifted by BMO Capital Markets from $70.00 to $80.00 in a research note published on Friday morning, The Fly reports.Several other equities analysts have also issued reports on the company. JMP Securities restated a buy rating and set a $26.00 target price on shares of Kura Oncology in a research report on Wednesday, December 15th. Credit Suisse Group decreased their target ...
1/10/2022 BMO Capital Markets Boosts Kura Oncology (NASDAQ:KURA) Price Target to $80.00 Daily Political ... from a sell rating to a hold rating in a research report on Tuesday, October 12th. Wedbush restated an outperform rating on shares of Kura Oncology in a research report on Monday, November 8th. JMP Securities reiterated a buy rating and issued a $26.00 target price on shares of Kura Oncology in a research report on Wednesday, December 15th. Finally, Credit Suisse Group dropped their target price on Kura Oncology ...
1/9/2022 Innovative Industrial Properties (NYSE:IIPR) Stock Rating Lowered by Zacks Investment Research baseballnewssource.com ... on the acquisition, ownership and management of specialized industrial properties leased to experienced, state-licensed operators for medical-use cannabis facilities. Innovative Industrial Properties, Inc. is based in San Diego, United States. “Separately, JMP Securities upped their price objective on Innovative Industrial Properties from $260.00 to $300.00 and gave the company an outperform rating in a report on Thursday, November 4th. One analyst has rated the stock with a ...
1/9/2022 Innovative Industrial Properties (NYSE:IIPR) Stock Rating Lowered by Zacks Investment Research - The Cerbat Gem thecerbatgem.com ... on the acquisition, ownership and management of specialized industrial properties leased to experienced, state-licensed operators for medical-use cannabis facilities. Innovative Industrial Properties, Inc. is based in San Diego, United States. “Separately, JMP Securities raised their price target on Innovative Industrial Properties from $260.00 to $300.00 and gave the stock an outperform rating in a research note on Thursday, November 4th. One equities research analyst has rated the ...
1/9/2022 Teleflex (NYSE:TFX) Stock Rating Lowered by Morgan Stanley com-unik.info ... target of $431.00. Morgan Stanley’s price objective points to a potential upside of 21.04% from the company’s current price.A number of other equities analysts have also recently issued reports on TFX. JMP Securities dropped their target price on Teleflex from $470.00 to $430.00 and set a “market outperform” rating for the company in a report on Friday, October 29th. Wells Fargo & Company dropped their target price ...
1/9/2022 Zacks Investment Research Downgrades Syros Pharmaceuticals (NASDAQ:SYRS) to Sell - Mayfield Recorder Mayfield Recorder ... Monday, November 8th. Roth Capital boosted their price objective on shares of Syros Pharmaceuticals from $20.00 to $23.00 and gave the stock a “buy” rating in a report on Thursday, September 23rd. Finally, JMP Securities restated a “buy” rating and issued a $20.00 price objective on shares of Syros Pharmaceuticals in a report on Tuesday, September 21st.Shares of SYRS opened at $3.50 on Friday. The company has ...